Radical Prostatectomy and Other Pelvic Surgeries

Effects on Erectile Function
  • Muammer Kendirci
  • Jeffrey Bejma
  • Wayne J. G. Hellstrom
Part of the Current Clinical Urology book series (CCU)


Preservation of erectile function following pelvic surgery is an important variable in a patient’s quality of life. Despite currently available oral and minimally invasive treatments, erectile dysfunction following pelvic surgery and radical prostatectomy challenges most urologists because of the lower-than-anticipated success rates. Postoperative pharmacological penile rehabilitation programs employing oral, transurethral, and intracavernosal vasoactive drugs are suggested to be beneficial for most patients, allowing a faster and more complete recovery of erectile function. New data on cavernous nerve protection and/or regeneration will likely evolve into a new therapeutic avenue for patients who undergo radical pelvic surgery. The ultimate aim is to increase the quality of life in patients undergoing pelvic surgery including radical prostatectomy.

Key Words

Erectile dysfunction radical prostatectomy pelvic surgery treatment cavernous nerve neuroprotection 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270(1): 83–90.Google Scholar
  2. 2.
    Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151(1): 54–61.PubMedGoogle Scholar
  3. 3.
    Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54(1): 8–29.PubMedGoogle Scholar
  4. 4.
    Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51(1): 15–36.PubMedCrossRefGoogle Scholar
  5. 5.
    Siegel T, Moul JW, Spevak M, Alvord WG, Costabile RA. The development of erectile dysfunction in men treated for prostate cancer. J Urol 2001; 165(2): 430–435.PubMedCrossRefGoogle Scholar
  6. 6.
    Crawford ED, Bennett CL, Stone NN, et al. Comparison of perspectives on prostate cancer: analyses of survey data. Urology 1997; 50(3): 366–372.PubMedCrossRefGoogle Scholar
  7. 7.
    Penson DF, Feng Z, Kuniyuki A, et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 2003; 21(6): 1147–1154.PubMedCrossRefGoogle Scholar
  8. 8.
    Montorsi F, Salonia A, Zanoni M, Colombo R, Pompa P, Rigatti P. Counselling the patient with prostate cancer about treatment-related erectile dysfunction. Curr Opin Urol 2001; 11(6): 611–617.PubMedCrossRefGoogle Scholar
  9. 9.
    Meuleman EJ, Mulders PF. Erectile function after radical prostatectomy: a review. Eur Urol 2003; 43(2): 95–101; discussion 2.PubMedCrossRefGoogle Scholar
  10. 10.
    Kendirci M, Hellstrom WJ. Current concepts in the management of erectile dysfunction in men with prostate cancer. Clin Prostate Cancer 2004; 3(2): 87–92.PubMedGoogle Scholar
  11. 11.
    Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982; 128(3): 492–497.PubMedGoogle Scholar
  12. 12.
    Fowler FJ Jr, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience:1988-1990 (updated June 1993). Urology 1993; 42(6): 622–629.PubMedCrossRefGoogle Scholar
  13. 13.
    Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994; 152(5 Pt 2): 1831–1836.PubMedGoogle Scholar
  14. 14.
    Geary ES, Dendinger TE, Freiha FS, Stamey TA. Nerve sparing radical prostatectomy: a different view. J Urol 1995; 154(1): 145–149.PubMedCrossRefGoogle Scholar
  15. 15.
    Walsh PC. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol 1998; 160 (6 Pt 2): 2418–2424.PubMedCrossRefGoogle Scholar
  16. 16.
    Hu JC, Elkin EP, Pasta DJ, et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol 2004; 171(2 Pt 1): 703–707; discussion 7,8.PubMedCrossRefGoogle Scholar
  17. 17.
    Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000; 283(3): 354–360.PubMedCrossRefGoogle Scholar
  18. 18.
    Potosky AL, Legler J, Albertsen PC, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000; 92(19): 1582–1592.PubMedCrossRefGoogle Scholar
  19. 19.
    Penson DF, McLerran D, Feng Z, et al. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol 2005; 173(5): 1701–1705.PubMedCrossRefGoogle Scholar
  20. 20.
    Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002; 347(11): 790–796.PubMedCrossRefGoogle Scholar
  21. 21.
    Mulhall JP, Yonover P, Sethi A, Yasuda G, Mohideen N. Radiation exposure to the corporeal bodies during 3-dimensional conformal radiation therapy for prostate cancer. J Urol 2002; 167(2 Pt 1): 539–542.PubMedCrossRefGoogle Scholar
  22. 22.
    Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1999; 54(3): 503–508.PubMedCrossRefGoogle Scholar
  23. 23.
    Kury P, Stoll G, Muller HW. Molecular mechanisms of cellular interactions in peripheral nerve regeneration. Curr Opin Neurol 2001; 14(5): 635–639.PubMedCrossRefGoogle Scholar
  24. 24.
    User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003; 169(3): 1175–1179.PubMedCrossRefGoogle Scholar
  25. 25.
    Moreland RB. Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res 1998; 10(2): 113–120.PubMedCrossRefGoogle Scholar
  26. 26.
    Leungwattanakij S, Bivalacqua TJ, Usta MF, et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003; 24(2): 239–245.PubMedGoogle Scholar
  27. 27.
    Yao KS, Clayton M, O’Dwyer PJ. Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J Natl Cancer Inst 1995; 87(2): 117–122.PubMedCrossRefGoogle Scholar
  28. 28.
    Klein LT, Miller MI, Buttyan R, et al. Apoptosis in the rat penis after penile denervation. J Urol 1997; 158(2): 626–630.PubMedCrossRefGoogle Scholar
  29. 29.
    Yamanaka M, Shirai M, Shiina H, et al. Loss of anti-apoptotic genes in aging rat crura. J Urol 2002; 168(5): 2296–2300.PubMedCrossRefGoogle Scholar
  30. 30.
    Mulhall JP, Graydon RJ. The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy. Int J Impot Res 1996; 8(2): 91–94.PubMedGoogle Scholar
  31. 31.
    Mulhall JP, Slovick R, Hotaling J, et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002; 167(3): 1371–1375.PubMedCrossRefGoogle Scholar
  32. 32.
    Savoie M, Kim SS, Soloway MS. A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. J Urol 2003; 169(4): 1462–1464.PubMedCrossRefGoogle Scholar
  33. 33.
    Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005; 173(5): 1673–1676.PubMedCrossRefGoogle Scholar
  34. 34.
    Montorsi F, Guazzoni G, Strambi LF, et al. Recovery of spontaneous erectile function after nervesparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997; 158(4): 1408–1410.PubMedCrossRefGoogle Scholar
  35. 35.
    Fraiman MC, Lepor H, McCullough AR. Changes in penile morphometrics in men with erectile dysfunction after nerve-sparing radical retropubic prostatectomy. Mol Urol 1999; 3(2): 109–115.PubMedGoogle Scholar
  36. 36.
    Walsh PC. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. J Urol 2000; 163(6): 1802–1807.PubMedCrossRefGoogle Scholar
  37. 37.
    McCullough AR. Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin North Am 2001; 28(3): 613–627.PubMedCrossRefGoogle Scholar
  38. 38.
    Rosen RC, Cappelleri JC, Gendrano N 3rd. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 2002; 14(4): 226–244.PubMedCrossRefGoogle Scholar
  39. 39.
    Lue TF, Gleason CA, Brock GB, Carroll PR, Tanagho EA. Intraoperative electrostimulation of the cavernous nerve: technique, results and limitations. J Urol 1995; 154(4): 1426–1428.PubMedCrossRefGoogle Scholar
  40. 40.
    Quinlan DM, Nelson RJ, Walsh PC. Cavernous nerve grafts restore erectile function in denervated rats. J Urol 1991; 145(2): 380–383.PubMedGoogle Scholar
  41. 41.
    Ball RA, Richie JP, Vickers MA Jr. Microsurgical nerve graft repair of the ablated cavernosal nerves in the rat. J Surg Res 1992; 53(3): 280–286.PubMedCrossRefGoogle Scholar
  42. 42.
    Kim ED, Scardino PT, Hampel O, Mills NL, Wheeler TM, Nath RK. Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy. J Urol 1999; 161(1): 188–192.PubMedCrossRefGoogle Scholar
  43. 43.
    Kim ED, Nath R, Kadmon D, et al. Bilateral nerve graft during radical retropubic prostatectomy:1-year followup. J Urol 2001; 165(6 Pt 1): 1950–1956.PubMedCrossRefGoogle Scholar
  44. 44.
    Scardino PT, Kim ED. Rationale for and results of nerve grafting during radical prostatectomy. Urology 2001; 57(6): 1016–1019.PubMedCrossRefGoogle Scholar
  45. 45.
    Anastasiadis AG, Benson MC, Rosenwasser MP, et al. Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: safe and technically feasible. Prostate Cancer Prostatic Dis 2003; 6(1): 56–60.PubMedCrossRefGoogle Scholar
  46. 46.
    Chang DW, Wood CG, Kroll SS, Youssef AA, Babaian RJ. Cavernous nerve reconstruction to preserve erectile function following non-nerve-sparing radical retropubic prostatectomy: a prospective study. Plast Reconstr Surg 2003; 111(3): 1174–1181.PubMedCrossRefGoogle Scholar
  47. 47.
    Canto EI, Nath RK, Slawin KM. Cavermap-assisted sural nerve interposition graft during radical prostatectomy. Urol Clin North Am 2001; 28(4): 839–848.PubMedCrossRefGoogle Scholar
  48. 48.
    Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 2004; 45(2): 123–133.PubMedCrossRefGoogle Scholar
  49. 49.
    Walsh PC. Nerve grafts are rarely necessary and are unlikely to improve sexual function in men undergoing anatomic radical prostatectomy. Urology 2001; 57(6): 1020–1024.PubMedCrossRefGoogle Scholar
  50. 50.
    Walsh PC. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. J Urol 2000; 164(1): 242.PubMedCrossRefGoogle Scholar
  51. 51.
    Burnett AL. Rationale for cavernous nerve restorative therapy to preserve erectile function after radical prostatectomy. Urology 2003; 61(3): 491–497.PubMedCrossRefGoogle Scholar
  52. 52.
    Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J Urol 2000; 164(6): 1929–1934.PubMedCrossRefGoogle Scholar
  53. 53.
    Gralnek D, Wessells H, Cui H, Dalkin BL. Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy. J Urol 2000; 163(4): 1166–1169, discussion 9-70.PubMedCrossRefGoogle Scholar
  54. 54.
    Burnett AL. Erectile dysfunction following radical prostatectomy. JAMA 2005; 293(21): 2648–2653.PubMedCrossRefGoogle Scholar
  55. 55.
    Padma-Nathan H, McCullough A, Giuliano F, Toler SM, Wohlhuter C, Shpilsky AB. Postoperative nightly administration of sildenafil citrate significantly improved the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 2003; 4(suppl): 375.Google Scholar
  56. 56.
    Brock G, Tu LM, Linet OI. Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment. Urology 2001; 57(3): 536–541.PubMedCrossRefGoogle Scholar
  57. 57.
    Raina R, Lakin MM, Agarwal A, Ausmundson S, Montague DK, Zippe CD. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy. Urology 2004; 63(3): 532–537, discussion 8.PubMedCrossRefGoogle Scholar
  58. 58.
    Montorsi F, Maga T, Strambi LF, et al. Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology 2000; 56(6): 906–911.PubMedCrossRefGoogle Scholar
  59. 59.
    Gontero P, Kirby R. Early rehabilitation of erectile function after nerve-sparing radical prostatectomy: what is the evidence? BJU Int 2004; 93(7): 916–918.PubMedCrossRefGoogle Scholar
  60. 60.
    Zippe CD, Jhaveri FM, Klein EA, et al. Role of Viagra after radical prostatectomy. Urology 2000; 55(2): 241–245.PubMedCrossRefGoogle Scholar
  61. 61.
    Zagaja GP, Mhoon DA, Aikens JE, Brendler CB. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology 2000; 56(4): 631–634.PubMedCrossRefGoogle Scholar
  62. 62.
    Lowentritt BH, Scardino PT, Miles BJ, et al. Sildenafil citrate after radical retropubic prostatectomy. J Urol 1999; 162(5): 1614–1617.PubMedCrossRefGoogle Scholar
  63. 63.
    Hong EK, Lepor H, McCullough AR. Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nerve-sparing radical retropubic prostatectomy (RRP). Int J Impot Res 1999; 11(suppl 1): S15–S22.PubMedCrossRefGoogle Scholar
  64. 64.
    Feng MI, Huang S, Kaptein J, Kaswick J, Aboseif S. Effect of sildenafil citrate on post-radical prostatectomy erectile dysfunction. J Urol 2000; 164(6): 1935–1938.PubMedCrossRefGoogle Scholar
  65. 65.
    Montorsi F, Salonia A, Zanoni M, et al. Current status of local penile therapy. Int J Impot Res 2002; 14(suppl 1): S70–S81.PubMedCrossRefGoogle Scholar
  66. 66.
    Raina R, Lakin MM, Agarwal A, et al. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology 2004; 63(5): 960–966.PubMedCrossRefGoogle Scholar
  67. 67.
    Brock G, Nehra A, Lipshultz LI, et al. Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol 2003; 170(4 Pt 1): 1278–1283.PubMedCrossRefGoogle Scholar
  68. 68.
    Montorsi F, Nathan HP, McCullough A, et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol 2004; 172(3): 1036–1041.PubMedCrossRefGoogle Scholar
  69. 69.
    Gontero P, Fontana F, Zitella A, Montorsi F, Frea B. A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy. BJU Int 2005; 95(3): 359–365.PubMedCrossRefGoogle Scholar
  70. 70.
    Raina R, Lakin MM, Agarwal A, et al. Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy:3-year follow-up. Urology 2003; 62(1): 110–115.PubMedCrossRefGoogle Scholar
  71. 71.
    Nehra A, Blute ML, Barrett DM, Moreland RB. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res 2002; 14(suppl 1): S38–S42.PubMedCrossRefGoogle Scholar
  72. 72.
    Cookson MS, Nadig PW. Long-term results with vacuum constriction device. J Urol 1993; 149(2): 290–294.PubMedGoogle Scholar
  73. 73.
    Khoudary KP, DeWolf WC, Bruning CO 3rd, Morgentaler A. Immediate sexual rehabilitation by simultaneous placement of penile prosthesis in patients undergoing radical prostatectomy: initial results in 50 patients. Urology 1997; 50(3): 395–399.PubMedCrossRefGoogle Scholar
  74. 74.
    Shaw K, Morey A, Jones L, Hakim L, Shannon S, Hellstrom WJG. Synchronous prosthetic implantation through a trans-scrotal incision: an outcome analysis. J Urol 2004; 171: 898A.Google Scholar
  75. 75.
    Lee ES, Kor DJ, Kuskowski MA, Santilli SM. Incidence of erectile dysfunction after open abdominal aortic aneurysm repair. Ann Vasc Surg 2000; 14(1): 13–19.PubMedCrossRefGoogle Scholar
  76. 76.
    Jimenez JC, Smith MM, Wilson SE. Sexual dysfunction in men after open or endovascular repair of abdominal aortic aneurysms. Vascular 2004; 12(3): 186–191.PubMedGoogle Scholar
  77. 77.
    Miles JR Jr, Miles DG, Johnson G Jr. Aortoiliac operations and sexual dysfunction. Arch Surg 1982; 117(9): 1177–1181.PubMedGoogle Scholar
  78. 78.
    Quayle JB. Sexual function after bilateral lumbar sympathectomy and aorto-iliac by-pass surgery. J Cardiovasc Surg (Torino) 1980; 21(2): 215–218.Google Scholar
  79. 79.
    Nevelsteen A, Beyens G, Duchateau J, Suy R. Aorto-femoral reconstruction and sexual function: a prospective study. Eur J Vasc Surg 1990; 4(3): 247–251.PubMedCrossRefGoogle Scholar
  80. 80.
    DePalma RG, Levine SB, Feldman S. Preservation of erectile function after aortoiliac reconstruction. Arch Surg 1978; 113(8): 958–962.PubMedGoogle Scholar
  81. 81.
    Flanigan DP, Stolar CJ, Pringle KC, Schuler JJ, Fisher E, Vidyasager D. Aortic thrombosis after umbilical artery catheterization. Arch Surg 1982; 117(3): 371–374.PubMedGoogle Scholar
  82. 82.
    van Schaik J, van Baalen JM, Visser MJ, DeRuiter MC. Nerve-preserving aortoiliac reconstruction surgery: anatomical study and surgical approach. J Vasc Surg 2001; 33(5): 983–989.PubMedCrossRefGoogle Scholar
  83. 83.
    Karkos CD, Wood A, Bruce IA, Karkos PD, Baguneid MS, Lambert ME. Erectile dysfunction after open versus angioplasty aortoiliac procedures: a questionnaire survey. Vasc Endovascular Surg 2004; 38(2): 157–165.PubMedCrossRefGoogle Scholar
  84. 84.
    Schlegel PN, Walsh PC. Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J Urol 1987; 138(6): 1402–1406.PubMedGoogle Scholar
  85. 85.
    Brendler CB, Steinberg GD, Marshall FF, Mostwin JL, Walsh PC. Local recurrence and survival following nerve-sparing radical cystoprostatectomy. J Urol 1990; 144(5): 1137–1140; discussion 40,41.PubMedGoogle Scholar
  86. 86.
    Schoenberg MP, Walsh PC, Breazeale DR, Marshall FF, Mostwin JL, Brendler CB. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer:10-year followup. J Urol 1996; 155(2): 490–494.PubMedCrossRefGoogle Scholar
  87. 87.
    Kessler TM, Burkhard FC, Perimenis P, et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 2004; 172(4 Pt 1): 1323–1327.PubMedCrossRefGoogle Scholar
  88. 88.
    Zippe CD, Raina R, Massanyi EZ, et al. Sexual function after male radical cystectomy in a sexually active population. Urology 2004; 64(4): 682–685, discussion 5,6.PubMedCrossRefGoogle Scholar
  89. 89.
    Spitz A, Stein JP, Lieskovsky G, Skinner DG. Orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique. J Urol 1999; 161(6): 1761–1764.PubMedCrossRefGoogle Scholar
  90. 90.
    Colombo R, Bertini R, Salonia A, et al. Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer. J Urol 2004; 171(5): 1819–1822, discussion 22.PubMedCrossRefGoogle Scholar
  91. 91.
    Meinhardt W, Horenblas S. Sexuality preserving cystectomy and neobladder (SPCN): functional results of a neobladder anastomosed to the prostate. Eur Urol 2003; 43(6): 646–650.PubMedCrossRefGoogle Scholar
  92. 92.
    Tomic R, Sjodin JG. Sexual function in men after radical cystectomy with or without urethrectomy. Scand J Urol Nephrol 1992; 26(2): 127–129.PubMedGoogle Scholar
  93. 93.
    Bjerre BD, Johansen C, Steven K. Sexological problems after cystectomy: bladder substitution compared with ileal conduit diversion. A questionnaire study of male patients. Scand J Urol Nephrol 1998; 32(3): 187–193.PubMedCrossRefGoogle Scholar
  94. 94.
    Hurny C, Holland J. Psychosocial sequelae of ostomies in cancer patients. CA Cancer J Clin 1985; 35(3): 170–183.PubMedCrossRefGoogle Scholar
  95. 95.
    Kim NK, Aahn TW, Park JK, et al. Assessment of sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in males with rectal cancer. Dis Colon Rectum 2002; 45(9): 1178–1185.PubMedCrossRefGoogle Scholar
  96. 96.
    Lindsey I, Guy RJ, Warren BF, Mortensen NJ. Anatomy of Denonvilliers’ fascia and pelvic nerves, impotence, and implications for the colorectal surgeon. Br J Surg 2000; 87(10): 1288–1299.PubMedCrossRefGoogle Scholar
  97. 97.
    Lindsey I, Mortensen NJ. Iatrogenic impotence and rectal dissection. Br J Surg 2002; 89(12): 1493, 1494.PubMedCrossRefGoogle Scholar
  98. 98.
    Santangelo ML, Romano G, Sassaroli C. Sexual function after resection for rectal cancer. Am J Surg 1987; 154(5): 502–504.PubMedCrossRefGoogle Scholar
  99. 99.
    Quah HM, Jayne DG, Eu KW, Seow-Choen F. Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer. Br J Surg 2002; 89(12): 1551–1556.PubMedCrossRefGoogle Scholar
  100. 100.
    Lindsey I, George B, Kettlewell M, Mortensen N. Randomized, double-blind, placebo-controlled trial of sildenafil (Viagra) for erectile dysfunction after rectal excision for cancer and inflammatory bowel disease. Dis Colon Rectum 2002; 45(6): 727–732.PubMedCrossRefGoogle Scholar
  101. 101.
    Cerqueira J, Moraes M, Glina S. Erectile dysfunction: prevalence and associated variables in patients with chronic renal failure. Int J Impot Res 2002; 14(2): 65–71.PubMedCrossRefGoogle Scholar
  102. 102.
    El-Bahnasawy MS, El-Assmy A, El-Sawy E, et al. Critical evaluation of the factors influencing erectile function after renal transplantation. Int J Impot Res 2004; 16(6): 521–526.PubMedCrossRefGoogle Scholar
  103. 103.
    Gittes RF, Waters WB. Sexual impotence: the overlooked complication of a second renal transplant. J Urol 1979; 121(6): 719,720.Google Scholar
  104. 104.
    Russo D, Musone D, Alteri V, et al. Erectile dysfunction in kidney transplanted patients: efficacy of sildenafil. J Nephrol 2004; 17(2): 291–295.PubMedGoogle Scholar
  105. 105.
    Zhang Y, Guan DL, Ou TW, et al. Sildenafil citrate treatment for erectile dysfunction after kidney transplantation. Transplant Proc 2005; 37(5): 2100–2103.PubMedCrossRefGoogle Scholar
  106. 106.
    Mansi MK, Alkhudair WK, Huraib S. Treatment of erectile dysfunction after kidney transplantation with intracavernosal self-injection of prostaglandin E1. J Urol 1998; 159(6): 1927–1930.PubMedCrossRefGoogle Scholar
  107. 107.
    Burgers JK, Nelson RJ, Quinlan DM, Walsh PC. Nerve growth factor, nerve grafts and amniotic membrane grafts restore erectile function in rats. J Urol 1991; 146(2): 463–468.PubMedGoogle Scholar
  108. 108.
    Te AE, Santarosa RP, Koo HP, et al. Neurotrophic factors in the rat penis. J Urol 1994; 152(6 Pt 1): 2167–2172.PubMedGoogle Scholar
  109. 109.
    Dahiya R, Chui R, Perinchery G, Nakajima K, Oh BR, Lue TF. Differential gene expression of growth factors in young and old rat penile tissues is associated with erectile dysfunction. Int J Impot Res 1999; 11(4): 201–206.PubMedCrossRefGoogle Scholar
  110. 110.
    Laurikainen A, Hiltunen JO, Thomas-Crusells J, et al. Neurturin is a neurotrophic factor for penile parasympathetic neurons in adult rat. J Neurobiol 2000; 43(2): 198–205.PubMedCrossRefGoogle Scholar
  111. 111.
    Sezen SF, Hoke A, Burnett AL, Snyder SH. Immunophilin ligand FK506 is neuroprotective for penile innervation. Nat Med 2001; 7(10): 1073,1074.CrossRefGoogle Scholar
  112. 112.
    Jung GW, Spencer EM, Lue TF. Growth hormone enhances regeneration of nitric oxide synthasecontaining penile nerves after cavernous nerve neurotomy in rats. J Urol 1998; 160(5): 1899–1904.PubMedCrossRefGoogle Scholar
  113. 113.
    Podlasek CA, Zelner DJ, Harris JD, et al. Altered Sonic hedgehog signaling is associated with morphological abnormalities in the penis of the BB/WOR diabetic rat. Biol Reprod 2003; 69(3): 816–827.PubMedCrossRefGoogle Scholar
  114. 114.
    Lee MC, El-Sakka AI, Graziottin TM, Ho HC, Lin CS, Lue TF. The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol 2002; 167(2 Pt 1): 761–767.PubMedCrossRefGoogle Scholar
  115. 115.
    Bochinski DJ, Hsieh PS, Chen KC, et al. The effect of vascular endothelial growth factor and brain derivated neurotrophic factor on cavernous nerve regeneration in a nerve-crush rat model. J Urol 2003; 169: 306.Google Scholar
  116. 116.
    Deng DY, Lin G, Bochinski DJ, Lin CS, Lue TF. Effect of prostagalandin E1 on angiogenesis and neural growth. J Urol 2003; 169: 313.CrossRefGoogle Scholar
  117. 117.
    Bakircioglu ME, Lin CS, Fan P, Sievert KD, Kan YW, Lue TF. The effect of adeno-associated virus mediated brain derived neurotrophic factor in an animal model of neurogenic impotence. J Urol 2001; 165(6 Pt 1): 2103–2109.PubMedCrossRefGoogle Scholar
  118. 118.
    Kim JH, Bennett NE, Yoshimura K, et al. Neurorecovery and improved erectile function using muscle derived stem cells (MDSC) in a model of post-radical prostatectomy erectile dysfunction. J Urol 2003; 169: 323.Google Scholar
  119. 119.
    Graziottin TM, Resplande J, Nunes L, Rogers R, Gholami S, Lue T. Long-term survival of autotransplanted major pelvic ganglion in the corpus cavernosum of adult rats. J Urol 2002; 168(1): 362–366.PubMedCrossRefGoogle Scholar
  120. 120.
    May F, Weidner N, Mrva T, Caspers C, Matiasek K, et al. Nerve guides seeded with Schwann cell are very effective for repair of ablated cavernosal nerves in rat. J Urol 2003; 169: 304.Google Scholar
  121. 121.
    Connolly SS, Yoo JJ, Soker S, McDougal WS, Atala A. Autonomic nerve regeneration for erectile function. J Urol 2003; 169: 324.CrossRefGoogle Scholar
  122. 122.
    Steiner JP, Dawson TM, Fotuhi M, et al. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 1992; 358(6387): 584–587.PubMedCrossRefGoogle Scholar
  123. 123.
    Steiner JP, Dawson TM, Fotuhi M, Snyder SH. Immunophilin regulation of neurotransmitter release. Mol Med 1996; 2(3): 325–333.PubMedGoogle Scholar
  124. 124.
    Sezen SF, Blackshaw S, Steiner JP, Burnett AL. FK506 binding protein 12 is expressed in rat penile innervation and upregulated after cavernous nerve injury. Int J Impot Res 2002; 14(6): 506–512.PubMedCrossRefGoogle Scholar
  125. 125.
    Burnett AL. Strategies to promote recovery of cavernous nerve function after radical prostatectomy. World J Urol 2003; 20(6): 337–342.PubMedGoogle Scholar
  126. 126.
    Kendirci M, Zsengellér Z, Bivalacqua TJ, et al. PARP inhibition preserves erectile function in rats after cavernous nerve injury. J Urol 2005; 174: 2054–2059.PubMedCrossRefGoogle Scholar
  127. 127.
    Kendirci M, Hellstrom WJG. Restoring erectile function: Proactive options after radical prostatectomy. Contemp Urol 2005; 17(4): 36–50.Google Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2006

Authors and Affiliations

  • Muammer Kendirci
  • Jeffrey Bejma
  • Wayne J. G. Hellstrom

There are no affiliations available

Personalised recommendations